Abdollahi Alireza, Hakimi Faezeh, Doomanlou Mahsa, Azadegan Azadeh
Associate Professor of Pathology, Department of Pathology, School of Medicine, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran; Associate Professor of Pathology, Thrombosis Hemostasis Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pathology, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Int J Hematol Oncol Stem Cell Res. 2016 Apr 1;10(2):61-9.
Preventing and starting early treatment of infections in patients whose immunity system is weak due to malignancies like leukemia can reduce mortality. This study aimed to determine microbial and antibiotic resistance patterns in clinical samples of patients with acute leukemia to start early treatment before the results of clinical tests are known.
In this cross-sectional study, the clinical samples of all patients hospitalized with the diagnosis of acute leukemia were cultured and their antibiogram was evaluated. Then, the data were analyzed by SPSS 18 based on the objectives of the study.
Of a total of 2,366 samples, 18.95% were reported to be positive blood samples, 22.96% were reported to be urine samples and 36% wound samples. E. coli was the most common bacteria isolated from the blood and urine cultures (34% in blood, 32% in urine culture) while Staphylococcus Aureus was the most common in the wound culture (35%). The highest level of sensitivity in the organisms with positive blood culture was to Ciprofloxacin, while in positive urine and wound culture was to Imipenem. The highest resistance in blood, urine and wound culture was to Cotrimoxazole.
According to results obtained from this study, it is necessary to conduct appropriate studies on this issue in specific conditions in our country. The findings of this study can be used in clinics for more accurate diagnosis, more effective treatment before the results of clinical tests are known and also for prevention of infection in cancer patients.
对于因白血病等恶性肿瘤导致免疫系统较弱的患者,预防感染并尽早开始治疗可降低死亡率。本研究旨在确定急性白血病患者临床样本中的微生物及抗生素耐药模式,以便在临床检测结果出来之前尽早开始治疗。
在这项横断面研究中,对所有诊断为急性白血病住院患者的临床样本进行培养,并评估其抗菌谱。然后,根据研究目的,使用SPSS 18对数据进行分析。
在总共2366份样本中,18.95%的血样呈阳性,22.96%的尿样呈阳性,36%的伤口样本呈阳性。大肠杆菌是从血培养和尿培养中分离出的最常见细菌(血培养中占34%,尿培养中占32%),而金黄色葡萄球菌是伤口培养中最常见的(占35%)。血培养阳性的微生物中对环丙沙星的敏感性最高,而尿培养和伤口培养阳性的微生物中对亚胺培南的敏感性最高。血、尿和伤口培养中耐药性最高的是复方新诺明。
根据本研究获得的结果,有必要在我国特定条件下针对此问题开展适当研究。本研究结果可用于临床,以进行更准确的诊断,在临床检测结果出来之前进行更有效的治疗,并预防癌症患者感染。